AmInvest Research Reports

Author: AmInvest   |   Latest post: Fri, 21 Feb 2020, 9:47 AM


Stocks on Radar - Duopharma Biotech (7148)

Author:   |    Publish date:

Duopharma Biotech may soon test the RM1.72 resistance level. With a healthy RSI level, a bullish bias may be present above this mark with a target price of RM1.78 and RM1.88. Meanwhile, it may continue moving sideways if it fails to cross the RM1.72 mark in the near term. In this case, the immediate support is anticipated at RM1.61, whereby traders may exit on a breach to avoid the risk of a further correction.

Trading Call: Buy upon breakout above RM1.72

Target: RM1.78, RM1.88 (time frame: 3-6 weeks)

Exit: RM1.61

Source: AmInvest Research - 24 Jan 2020

Share this

Related Stocks

Chart Stock Name Last Change Volume 
DPHARMA 1.63 +0.01 (0.62%) 1,188,200 

  Be the first to like this.


420  316  517  739 

Top 10 Active Counters
 EDUSPEC 0.03+0.005 
 XOX 0.050.00 
 PWORTH 0.02-0.005 
 XDL 0.17+0.01 
 PWRWELL 0.3750.00 
 PERDANA 0.47-0.01 
 ISTONE 0.24+0.015 
 MTOUCHE 0.175-0.015 
 INNATURE 0.59-0.065 
 HSI-H8T 0.48+0.045 
Partners & Brokers